No activity today, make something!
afya
ProstateCa
Markdown Help
Search globally
Save Tiddler
Revert Changes
Cancel Edit
<
> <
> second most common cancer in adult males in UK most common malignant condition in men over 65 years. ''Risk factors'' increasing age Afro-Caribbean ethnicity ''Features'' bladder outlet obstruction: hesitancy, urinary retention haematuria, haematospermia pain: back, perineal or testicular digital rectal examination: asymmetrical, hard, nodular enlargement with loss of median sulcus ''Management'' ''Localised prostate cancer (T1/T2)'' Treatment depends on life expectancy and patient choice conservative: active monitoring & watchful waiting radical prostatectomy radiotherapy: external beam and brachytherapy ''Localised advanced prostate cancer (T3/T4)'' hormonal therapy: see below radical prostatectomy radiotherapy: external beam and brachytherapy ''Metastatic prostate cancer disease'' - hormonal therapy //Synthetic GnRH agonist// e.g. Goserelin (Zoladex) cover initially with anti-androgen to prevent rise in testosterone (tumour flare via LH release) - start Cyproterone 3/7 before Zoladex //Anti-androgen// cyproterone acetate prevents DHT binding from intracytoplasmic protein complexes //Orchidectomy//
Autocomplete tags from:
Global tags
Local tags
Cancer